C3 complement 24h urine
Selected indexed studies
- Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study. (Lancet, 2025) [PMID:41016405]
- Prospective analysis of B cell subset dynamics following telitacicept treatment in systemic lupus erythematosus. (Arthritis Res Ther, 2025) [PMID:40533865]
- Telitacicept use in children with IgA vasculitis nephritis: preliminary observations. (Pediatr Nephrol, 2025) [PMID:40042623]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Telitacicept use in children with IgA vasculitis nephritis: preliminary observations. (2025) pubmed
- Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study. (2025) pubmed
- Prospective analysis of B cell subset dynamics following telitacicept treatment in systemic lupus erythematosus. (2025) pubmed
- The relevance of complement levels in assessing the activity of lupus nephritis of different pathological types. (2025) pubmed
- Secukinumab-induced systemic lupus erythematosus in psoriatic arthritis. (2023) pubmed
- Primary Sjögren's syndrome presenting with non-diffuse membranoproliferative glomerulonephritis-like lesions in cryoglobulinemic glomerulonephritis: a case report. (2025) pubmed
- The Significance of Newly Derived Disease Activity Parameters Neutrophil/Albumin Ratio, Neutrophil/Complement C3 Ratio, and Albumin/Globulin Ratio in a Group of Patients With Lupus Nephritis. (2025) pubmed
- A multi-dimensional risk signature for lupus nephritis in systemic lupus erythematosus: integrating symptoms, biochemistry and immune cell profiles. (2025) pubmed
- Renal handling of the third (C3) and fourth (C4) components of the complement system in the nephrotic syndrome. (1976) pubmed
- Influence of air pollution on renal activity in patients with childhood-onset systemic lupus erythematosus. (2020) pubmed